Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 47kWORD 10k
15 June 2020
Question for written answer
to the Commission
Rule 138
Luisa Regimenti (ID), Silvia Sardone (ID), Annalisa Tardino (ID), Elena Lizzi (ID), Gianantonio Da Re (ID), Rosanna Conte (ID), Gianna Gancia (ID), Stefania Zambelli (ID), Simona Baldassarre (ID), Catherine Griset (ID), Maximilian Krah (ID), Annika Bruna (ID), Gilles Lebreton (ID), Aurelia Beigneux (ID), Fulvio Martusciello (PPE), Daniela Rondinelli (NI), France Jamet (ID), Jadwiga Wiśniewska (ECR), Athanasios Konstantinou (NI)
 Subject: Endometriosis: research under the new 2021-2027 health programme

One out of every 10 women of childbearing age suffers from endometriosis, a painful condition of the uterus which causes pain and in some cases disability or sterility.

The precise causes of endometriosis are so far unknown and no effective cure for the condition has been found to data. In addition, a definitive diagnosis cannot be obtained without an invasive surgical procedure.

Endometriosis has a major socio-economic impact on a woman’s personal and family life, but also on her working life, as she has to resort often to taking either certified or uncertified sick leave. It also has a financial impact as the few forms of treatment currently available are costly and long-term.

In view of the resolution adopted by Parliament on promoting gender equality in mental health and clinical research, which cited endometriosis specifically as an example of discrimination in research into female pathologies and their treatment, and the importance of promoting research into the causes, prevention and treatment of endometriosis, can the Commission answer the following questions:

1. How does it plan to promote research into endometriosis under the EU’s health programme for 2021-2027?

2. Will it foster exchange of clinical data between Member States, starting with analysis of data by geographical area, in order to set up common strategies for action on this disorder?


(1)This question is supported by Members other than the authors: Marco Dreosto (ID), Isabella Tovaglieri (ID), Dominique Bilde (ID)
Original language of question: IT
Last updated: 3 July 2020Legal notice - Privacy policy